About Us
   

  Manufacturing
   

  Quality
   

  R&D
   

  Products
   

  Marketing
   

  News Room
   

  Enquiry Form
   

  Order Form
   

  Opportunities
   

  Sitemap
   

  Contact Us
   
 
   
 
   
DGRNIL
Lansoprazole Capsules
 
Description

It reduces gastric acid secretion through a highly selective mechanism of action. It produces specific mechanism of action. It produces specific dose dependent inhibition of the enzyme’ H+, K+-ATPase (the proton pump) in the parietal cell. As this action inhibits the final stage of gastric acid formation there is effective inhibition of both basal and stimulated acid secretion irrespective of the stimulus to acid formation.

Composition

Each Capsule Contains:Lansoprazole 30 mg. (As Entericcoated Granules)Approved colors used in Empty Hard Gelatin Capsules.

Indications

Duodenal ulcer, Gastric Ulcer, Reflux Oesophagitis, Zollinger Ellison Syndrome

Dosage

30mg once daily.

Pack

10 Strips of 10 Capsules each